SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-050309
Filing Date
2018-08-08
Accepted
2018-08-08 06:50:52
Documents
62
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a18-14101_110q.htm 10-Q 816441
2 EX-31.1 a18-14101_1ex31d1.htm EX-31.1 10989
3 EX-31.2 a18-14101_1ex31d2.htm EX-31.2 11349
4 EX-32.1 a18-14101_1ex32d1.htm EX-32.1 11501
  Complete submission text file 0001104659-18-050309.txt   4923332

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT lptx-20180630.xml EX-101.INS 1097751
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lptx-20180630.xsd EX-101.SCH 49074
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lptx-20180630_cal.xml EX-101.CAL 32150
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lptx-20180630_def.xml EX-101.DEF 176984
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT lptx-20180630_lab.xml EX-101.LAB 427253
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lptx-20180630_pre.xml EX-101.PRE 322094
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37990 | Film No.: 18999723
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences